Traumatic Brain Injury (TBI) is a well validated risk factor for Alzheimer's Disease (AD) along with other factors such as age, family history, genetic predisposition, cardiovascular disease, social/cognitive engagement, and education. Our lab is intrinsically involved in deciphering the link between TBI and the development of dementia/AD by utilizing cognitive assessments, neuroimaging, and clinical biomarkers to provide innovative therapeutic treatments.

Learn from Dr. Adamson

Transcranial Magnetic Stimulation


Efficacy of Repetitive Transcranial Magnetic Stimulation for Improvement of Memory in Older Adults With TBI

The proposed study will evaluate the safety, durability and efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) as a promising non-invasive therapeutic treatment for improving memory in older adults with mild or moderate Traumatic Brain Injury (TBI) who have been experiencing residual memory or cognitive problems that affect daily functioning.

Patients with mild and moderate TBI will be assigned randomly to receive active or sham treatment using Repetitive Transcranial Magnetic Stimulation. 

RTMS will be delivered via magventure machine, on an approved FDA IDE protocol to DLPFC region to improve memory in older adults (veterans and non-veterans) with mild and moderate TBI.


Diagnostic Models

Our lab employs innovative algorithms to explore white matter tracts, functional connectivity, cortical thickness across the disease spectrum of traumatic brain injury (TBI), normal aging, dementia/Alzheimer's disease (AD), and psychiatric comorbid disorders such as depression, anxiety, and post-traumatic disorder (PTSD). 

Transcranial Magnetic Stimulation

What Happens During rTMS

Magnetic Resonance Imagery

What Happens During an MRI


Enhancing Neuro Imaging Genetics Meta-Analysis

The ENIGMA Consortium brings together researchers in imaging genomics to understand brain structure, function, and disease, based on brain imaging and genetic data. We welcome brain researchers, imagers, geneticists, methods developers, and others interested in cracking the neuro-genetic code!

Our lab is actively involved in several working groups such as functional MRI, traumatic brain injury, intimate partner violence, and COVID-19. The goal is to translate evidence based research in collaboration with international researchers and develop guidelines for imaging and genomic research and treatment protocols.

Using tractography methods developed at the Yeatman Lab at Stanford on diffusion weighted imaging (DWI) our lab is able to characterize 20 white matter fascicles (tracts) across an injured brain.